Medical Letter on the CDC and FDA

Colon Cancer - Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)

Columbia Laboratories, Inc. - Columbia Laboratories and PharmaBio Agree to One Year Extension of Final Payment under STRIANT® Financing Agreement

Contact Lens - A Drug-Dispensing Contact Lens

Depression - Labopharm receives complete response letter from the U.S. FDA for novel antidepressant

Drug Safety - SafeTScribe Technologies' Low Cost Time and Temperature Sensing Ink Enhances Food and Drug Safety and Quality Assurance

Edelman Public Relations - Data show ATryn effectively prevents serious blood clots

Elekta - Elekta CMS Software Receives FDA 510(k) Clearance for Monaco VMAT Treatment Planning Solution

Embera NeuroTherapeutics, Inc. - Embera NeuroTherapeutics Announces Expansion of Management Team after Successful Completion of Pilot Study of Cocaine Addiction Treatment

Family Research Council - FRC: Ryan Bill Increases Abortion While Claiming to 'Reduce Need' for Abortion

Genentech, Inc. - Xeloda®-Oxaliplatin Combination XELOX Shown to Be More Effective Than Standard Chemotherapy Regimen in Adjuvant Colon Cancer

Genzyme Corp. - Genzyme Delivers Solid Second-Quarter Financial Results

Golden Helix, Inc. - Golden Helix Offers Assistance for Rosetta Syllego Users

HCD Research - Docs Say No to Pulling Drugs Containing Acetaminophen off the Market

HemCon Medical Technologies, Inc. - Next-Generation Hemostatic Dressing Available for Military Emergencies

Hepatitis C Virus - FDA Approves VITROS(R) Anti-HCV Assay for Use On VITROS 5600(R) Integrated and VITROS 3600(R) Immunodiagnostic Systems

HIV/AIDS - 96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy

HIV/AIDS - Abbott HIV Test Demonstrates Earlier Disease Detection

HIV/AIDS Co-Infection - BD/PEPFAR Lab-Strengthening Initiative Marks Progress in Fight Against HIV/AIDS and TB in Sub-Saharan Africa

Hypertension - FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

Incyte Corporation - Incyte Reaches Agreement with FDA on a Special Protocol Assessment for INCB18424 in Myelofibrosis

Jewish Hospital - World's First Cardiac Adult Stem Cell Patient Receives Infusion

Keratoconus - SynergEyes, Inc. Launches New Hybrid Lens Design for Keratoconus Patients

Lung Cancer - Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics

Lupus - First Potential Lupus-Specific Treatment in Sight

Merck - ISENTRESS® raltegravir, from Merck, was as Effective as Efavirenz at Suppressing HIV Viral Load and Increasing CD4 Cell Counts in Treatment-Naive Patients up to 144 Weeks When Used in Combination Therapy

Multiple Sclerosis - Merck Serono Submits Application for Cladribine Tablets as Multiple Sclerosis Therapy in Europe

Namic - CNN's Dr. Sanjay Gupta to Receive Mickey Leland Humanitarian Achievement Award at 23rd Annual NAMIC Conference

National Dental Pulp Laboratory, Inc. - National Dental Pulp Laboratory Offers Facts about the Promise of Dental Pulp

Non-Melanoma Skin Cancer - First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

Oncology - Comprehensive VMAT Solution From Elekta on Center Stage at 2009 AAPM Annual Meeting

Osteoporosis - FDA Approves Expanded Use of Lilly's FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis

Perfusion - Masimo Receives FDA Clearance for New Rainbow(R) Resposable(TM) Sensor System

Pharmaceuticals - QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo(TM) IV Pain Therapy

Pharmalucence, Inc. - Pharmalucence, Inc. Announces FDA Approval for its Generic Sestamibi Kit

Recall InfoLink - Recall InfoLink Announces Comprensive Offering for Product Tracking and Reporting and Consumer Safety

Regeneron Pharmaceuticals, Inc. - Regeneron Receives European Medicines Agency Positive Opinion for Marketing Authorization of Rilonacept for the Treatment of Cryopyrin-Associated Periodic Syndromes CAPS

Regulatory Actions - NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study

Regulatory Actions - Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market

Renaissance Life & Health Insurance Company of America - Renaissance Grants $3,000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly

Research and Markets - New Innovations in in-Vitro Diagnostics Report - New Technologies, Growth Opportunities, and the Future Market Outlook

Safe Harbor - Safe Harbor(R) Helps Hollywood Say Bye-Bye to Mercury Fears in Fish

Seattle Genetics, Inc. - Seattle Genetics Initiates Brentuximab Vedotin SGN-35 Retreatment Clinical Trial

Signostics Inc. - Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors

SpineAlign Medical, Inc. - SpineAlign Medical Treats First Patient in U.S. with New, Innovative System for Vertebral Compression Fracture Repair

Stem Cell Research - World's First Cardiac Adult Stem Cell Patient and Physicians Discuss Clinical Trial

Surgery - Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

Terumo Cardiovascular Systems - Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda AAA Stent Graft System

The Dow Chemical Company - Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres

Therapy - Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

Transcat, Inc. - Transcat, Inc. Partners with FLIR in the Test & Measurement Market

Turner Construction Company - Turner Selected by Centers for Disease Control and Prevention to Manage Construction of 311,000 Sq. Ft. Office Facility Adjacent to CDC Headquarters in Atlanta, GA

Universal Detection Technology - Universal Detection Technology Bio-Detection Kits Gain Momentum in Commercial Sector

University of Leicester - Stuff of stink bombs investigated for role in pregnancy